The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Pilot study of an enhanced telehealth program for patients with prostate cancer.
 
Erin Bange
Consulting or Advisory Role - Flatiron Health
 
Anne Reiner
No Relationships to Disclose
 
Christine Liebertz
No Relationships to Disclose
 
Susan Chimonas
No Relationships to Disclose
 
Robert Daly
Stock and Other Ownership Interests - CVS Health (I); Lilly (I); Roche/Genentech
Consulting or Advisory Role - Varian Medical Systems
 
Charlotte Malling
No Relationships to Disclose
 
Shu Lei
No Relationships to Disclose
 
Rosaline Campbell
No Relationships to Disclose
 
Kristina Stevanovic
No Relationships to Disclose
 
Jessie Holland
No Relationships to Disclose
 
Rachel Sanford
No Relationships to Disclose
 
Sahil Doshi
No Relationships to Disclose
 
Gilad Kuperman
No Relationships to Disclose
 
Fernanda Polubriaginof
No Relationships to Disclose
 
Peter Stetson
No Relationships to Disclose
 
Deb Schrag
Stock and Other Ownership Interests - Merck (I)
Consulting or Advisory Role - Genentech; JAMA-Journal of the American Medical Association
Research Funding - AACR (Inst); GRAIL (Inst)
Patents, Royalties, Other Intellectual Property - PRISSMM model is trademarked and curation tools are available to academic medical centers and government under creative commons license.
 
Katherine Panageas
Stock and Other Ownership Interests - 23andMe; EyePoint Pharmaceuticals (I); Kyverna Therapeutics (I); Vincerx Pharma
Research Funding - AACR (Inst)
Travel, Accommodations, Expenses - AACR Project GENIE; The Robert A. Winn Diversity in Clinical Trials Award Program (Winn Awards) in collaboration with the American Association for Cancer Research (AACR), Bristol Myers Squibb Foundation
 
Michael Morris
Employment - Memorial Sloan-Kettering Cancer Center
Stock and Other Ownership Interests - Doximity
Consulting or Advisory Role - Ambrx; Amgen; Arvinas; Blue Earth Diagnostics; Bristol-Myers Squibb/Celgene; Clarity Pharmaceuticals; Convergent Therapeutics; Core Medica; Curium Pharma; Daiichi; Exelixis; Flare Therapeutics; Fusion Pharmaceuticals; ITM Isotope Technologies Munich; Lantheus Medical Imaging; Mashup Media; Pfizer; POINT Biopharma; Progenics; Telix Pharmaceuticals; Transtherabio; Z-Alpha
Research Funding - Astellas Pharma (Inst); AstraZeneca (Inst); Janssen (Inst); Novartis (Inst)
Patents, Royalties, Other Intellectual Property - Telix Pharmaceuticals (Inst)
Travel, Accommodations, Expenses - Amgen; APCCC; AstraZeneca; Memorial Sloan-Kettering Cancer Center
(OPTIONAL) Uncompensated Relationships - Amgen; Bayer; Halda Therapeutics; Janssen Oncology; Novartis; Wren Laboraties